N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA Journal Article


Authors: Schnappauf, F.; Hake, S. B.; Camacho-Carvajal, M. M.; Bontron, S.; Lisowska-Grospierre, B.; Steimle, V.
Article Title: N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA
Abstract: Major histocompatibility complex (MHC) class II molecules play an essential role for the cellular immune response by presenting peptide antigens to CD4+ T cells. MHC class II molecules and genes show a highly complex expression pattern, which is orchestrated through a master regulatory factor, called CIITA (class II transactivator). CIITA controls MHC class II expression not only qualitatively, but also quantitatively, and has therefore a direct influence on the CD4 T cell-dependent immune response. CIITA is itself tightly regulated not only on the transcriptional level, but as we show here also on the protein level. CIITA is subjected to a very rapid protein turnover and shows a half-life of about 30 min. Inhibition of degradation by proteasome inhibitors and the identification of ubiquitylated CIITA intermediates indicate that the degradation of CIITA is mediated by the ubiquitin-proteasome system. We identified two regions mediating degradation within the N-terminal domain of CIITA. N-terminal fusions or deletions stabilized CIITA, indicating that the N termini contribute to degradation. Several non-functional CIITA mutants are partially stabilized, but we provide evidence that transcriptional activity of CIITA is not directly linked to degradation.
Keywords: controlled study; human cell; promoter region; sequence deletion; ubiquitin; protein function; t lymphocyte; proteasome inhibitor; proteasome endopeptidase complex; gene expression; protein degradation; protein metabolism; cell line; transfection; nuclear proteins; cellular immunity; immune response; amino acid sequence; molecular sequence data; amino terminal sequence; quantitative analysis; transactivator protein; major histocompatibility antigen class 2; protein structure, tertiary; trans-activators; cd4 antigen; major histocompatibility complex; genes, mhc class ii; multienzyme complexes; half life time; antigen presenting cell; drug stability; half-life; mutant; regulator protein; qualitative analysis; molecular stability; ubiquitin-proteasome system; cysteine endopeptidases; protein sorting signals; humans; human; priority journal; article; mhc class ii gene regulation
Journal Title: European Journal of Immunology
Volume: 33
Issue: 8
ISSN: 0014-2980
Publisher: Wiley V C H Verlag Gmbh  
Date Published: 2003-08-01
Start Page: 2337
End Page: 2347
Language: English
DOI: 10.1002/eji.200323490
PUBMED: 12884309
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 12 September 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sandra Hake
    5 Hake